LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
38.63
+0.43 (1.13%)
At close: Aug 29, 2025, 4:00 PM
39.25
+0.62 (1.60%)
After-hours: Aug 29, 2025, 7:16 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $1.10 billion as of August 29, 2025. Its market cap has increased by 70.51% in one year.
Market Cap
1.10B
Enterprise Value
893.34M
1-Year Change
70.51%
Ranking
Category
Stock Price
38.63
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $1.10B, an increase of 166.37%. That is a compound annual growth rate of 97.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 1.10B | 38.78% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |